BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Mologen AG 

P.O. Box 332140

Berlin    D - 14180  Germany
Phone: 49-0-30-857-576-0 Fax: 49-0-30-857-576-50


SEARCH JOBS


Industry
Biotechnology

Segment
Gene Therapy





 Company News
Mologen AG (MOLGF.PK): DSLIM® Shows Superior Immunoactivation Capabilities 4/8/2014 2:01:28 PM    More...
Mologen AG (MOLGF.PK): Change Within the Supervisory Board - Chairman Resigns Due to Health Reasons as Announced - Successor Nominated 7/1/2013 7:19:02 AM    More...
Mologen AG (MOLGF.PK) Expands Its Executive Board by Chief Medical Officer 3/26/2013 12:08:42 PM    More...
Mologen AG (MOLGF.PK): Research and Financing Successes in the 2012 Financial Year 3/21/2013 12:31:30 PM    More...
Mologen AG (MOLGF.PK): Promising Start to 2012 Business Year - Quarterly Report Submitted 5/15/2012 11:42:03 AM    More...
Mologen AG (MOLGF.PK) -- Excellent Outcome for Phase 2 Colorectal Cancer Study With MGN1703 -- Primary Endpoint Achieved 5/14/2012 10:39:16 AM    More...
Mologen AG (MOLGF.PK) Attains the Goals of the Renal Cancer Study With MGN1601 Ahead of Schedule 11/21/2011 10:21:28 AM    More...
Mologen AG (MOLGF.PK) Will Next Clinically Investigate the Efficacy of MGN1703 in Lung Cancer 6/7/2011 9:46:12 AM    More...
Mologen AG (MOLGF.PK): Cell-Based Gene Therapy against Cancer (MGN1601) Granted Patent Protection in Europe 2/23/2011 10:29:24 AM    More...
Mologen AG (MOLGF.PK): A Further Clinical Study has Currently been Started - a New Therapy Approach for the Treatment of Renal Cancer 12/14/2010 10:47:43 AM    More...
1234567

//-->